Skip to main content
Journal of Genetic Engineering and Biotechnology
Fig. 2 | Journal of Genetic Engineering and Biotechnology

Fig. 2

From: Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients

Fig. 2

Ratio charts of MLPA results for some CLL patients using SALSA MLPA probemix P038-B1 CLL. Probe ratios below 0.7 (bottom line) or above 1.3 (top line) are usually regarded as indicative of a deletion or duplication, respectively. a is a patient having trisomy 12, b is a patient having 11q deletion and trisomy 12, c is a patient having 13q deletion, d is a patient having 13q deletion (this patient is having 30% mosaic 13q deletion by FISH), and e is a patient having 17p deletion

Back to article page